Home/Filings/4/0001209191-21-026381
4//SEC Filing

Girao Tiago 4

Accession 0001209191-21-026381

CIK 0001785345other

Filed

Apr 11, 8:00 PM ET

Accepted

Apr 12, 6:01 PM ET

Size

5.3 KB

Accession

0001209191-21-026381

Insider Transaction Report

Form 4
Period: 2021-04-08
Girao Tiago
Director
Transactions
  • Award

    Stock Option (right to buy)

    2021-04-08+36,00036,000 total
    Exercise: $10.16Exp: 2031-04-07Common Stock (36,000 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying this option will vest and become exercisable in 36 equal monthly installments beginning on April 8, 2021, subject to the Reporting Person's continuous service with the Issuer on each such date.

Issuer

Landos Biopharma, Inc.

CIK 0001785345

Entity typeother

Related Parties

1
  • filerCIK 0001618670

Filing Metadata

Form type
4
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 6:01 PM ET
Size
5.3 KB